MyAverix Finance
HK · Healthcare
Hangzhou Jiuyuan Gene (2566)
Biotechnology
Hangzhou Jiuyuan Gene (2566) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $1.59B, P/E ratio is 10.28, net margin is 10.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2566
Hangzhou Jiuyuan Gene (2566) — FAQ
What is Hangzhou Jiuyuan Gene's market cap?
Hangzhou Jiuyuan Gene (2566) has a reported market cap of $1.59B (data as of 2026-05-21).
What is 2566's P/E ratio?
The price-to-earnings (P/E) ratio for Hangzhou Jiuyuan Gene (2566) is 10.28 (data as of 2026-05-21).
Does Hangzhou Jiuyuan Gene pay a dividend?
Dividend yield is not available in the current snapshot for Hangzhou Jiuyuan Gene (2566). Check the MyAverix Finance app for the latest dividend data.
What sector is Hangzhou Jiuyuan Gene in?
Hangzhou Jiuyuan Gene (2566) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2566 listed on?
2566 is listed on HK.
What is Hangzhou Jiuyuan Gene's net margin?
Hangzhou Jiuyuan Gene (2566) reports a net margin of 10.6% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.